|
⚲
|
| Trimel Biopharma Holdings Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001477830 |
| Sale | 2009-11-23 ($0.3 M Offered, $0.3 M Sold) |
| Fund | |
| Phone | 2462289888 |
| Address | The Grove Belleville St Michael, BB11113 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Eugene Melnyk | |
| Liza Harridyalsodha |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
New Jersey Asia Investors Evergreen, LP
✚
|
0.0 | |
|
New Jersey Asia Investors III, LP
✚
|
0.0 | |
|
NewLeaf Symbiotics, Inc.
✚
|
0.0 | |
|
Silver Legacy Capital Corp
✚
|
0.0 | |
|
Silver Lining Asset Partners LP
✚
|
0.0 | |
|
Silverlink Communications Inc
✚
|
0.0 | |
|
New Lab Investor Group, LLC
✚
|
0.0 | |
|
Cap-Ex LLC
✚
|
0.0 | |
|
200 Industrial Boulevard, LLC
✚
|
0.0 | |
|
Lansdowne DM Long Only Cayman Master LP
✚
|
0.0 |